Showing results (381-390 of 3,164) with videos related to
Sort By:
Pageof 317
Translational Oncology|February 27, 2024
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancerShreya Sharma, Harsha Rani, Yeshwanth Mahesh, et al.Translational Oncology|February 27, 2024
Comprehensive analysis and experimental verification of the mechanism of action of T cell-mediated tumor-killing related genes in Colon adenocarcinomaJing Chen, Zhengfang Wang, Qin Zhu, et al.Translational Oncology|February 27, 2024
The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell compositionClaudia Kalla, German Ott, Francesca Finotello, et al.Translational Oncology|January 23, 2024
Lysosomal alkalinization in nutrient restricted cancer cells activates cytoskeletal rearrangement to enhance partial epithelial to mesenchymal transitionH Hazal Hüsnügil, Aliye Ezgi Güleç Taşkıran, Ismail Güderer, et al.Translational Oncology|November 4, 2023
Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrenceGiovanni Marchi, Anna Rajavuori, Mai T N Nguyen, et al.Translational Oncology|November 6, 2023
Epigenetic modifications: Key players in cancer heterogeneity and drug resistanceHana Q Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.Translational Oncology|November 5, 2023
Hsa_circ_0020134 promotes liver metastasis of colorectal cancer through the miR-183-5p-PFN2-TGF-β/Smad axisJin-Hao Yu, Jia-Nan Tan, Guang-Yu Zhong, et al.Translational Oncology|July 13, 2024
Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeuticsMudassir Hassan, Lütfi Tutar, Duygu Sari-Ak, et al.Translational Oncology|June 29, 2024
Plasma extracellular vesicles proteomics in meningioma patientsYiqiang Zhou, Yanxin Lu, Xiaolong Wu, et al.Translational Oncology|July 11, 2024
CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcriptionYing Cui, Yuxi Zhao, Guihua Shen, et al.Pageof 317